{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:28:21Z","timestamp":1778628501585,"version":"3.51.4"},"reference-count":44,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T00:00:00Z","timestamp":1327363200000},"content-version":"vor","delay-in-days":11030,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[1981,11,12]]},"abstract":"<jats:p>Amoxapine, a new antidepressant, exhibits both antidepressant and neuroleptic effects in laboratory animals and in humans. Evidence from human studies (extrapyramidal reactions, hyperprolactinemia, and galactorrhea), animal screening tests, and neurochemical experiments support the contention that amoxapine or a metabolite occasionally produces neuroleptic\u2010like effects. Amoxapine's neuroleptic activity may derive from 7\u2010hydroxy\u2010amoxapine, a minor metabolite in humans, which exhibits significant dopamine receptor\u2010blocking activity. Evidence for an early antidepressant effect of amoxapine in the treatment of depressive illness has not been consistently demonstrated. In comparable doses (roughly twice the dose of imipramine or amitriptyline), amoxapine appears to be similar to reference antidepressants in efficacy, unwanted effects, and acute toxicity.<\/jats:p>","DOI":"10.1002\/j.1875-9114.1981.tb02538.x","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T10:56:31Z","timestamp":1450263391000},"page":"163-178","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Amoxapine \u2014 An Antidepressant With Some Neuroleptic Properties?: A Review of Its Chemistry, Animal Pharmacology and Toxicology, Human Pharmacology, and Clinical Efficacy"],"prefix":"10.1002","volume":"1","author":[{"given":"R. Bruce","family":"Lydiard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan J.","family":"Gelenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,24]]},"reference":[{"key":"e_1_2_1_1_2_2","first-page":"107","article-title":"The neuropharmacological actions of amoxapine","volume":"233","author":"Greenblatt EN","year":"1978","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"e_1_2_1_1_3_2","first-page":"814","article-title":"Amoxapine in experimental psychopharmacology: A neuroleptic or an anti\u2010depressant?","volume":"29","author":"Chermat R","year":"1979","journal-title":"Arzneimittelforsch"},{"key":"e_1_2_1_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(63)90005-5"},{"key":"e_1_2_1_1_5_2","first-page":"1","article-title":"Amoxapine","volume":"2","author":"Greenblatt EN","year":"1979","journal-title":"Pharmacol Biochem Prop Drug Sub"},{"key":"e_1_2_1_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600680224"},{"key":"e_1_2_1_1_7_2","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/0006-2952(79)90017-0","article-title":"2\u2010chloro\u201011 (1\u2010piperazinyl) dibenz [b, f] oxazepine (amoxapine), an antidepressant with antipsychotic properties\u2014a possible role for 7\u2010hydroxyamoxapine","volume":"28","author":"Coupet J","year":"1979","journal-title":"Biochem Pharmacol"},{"key":"e_1_2_1_1_8_2","first-page":"567","article-title":"Antidepressant drug action and presynaptic alpha\u2010receptors","volume":"55","author":"Collis MG","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"e_1_2_1_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(76)90261-4"},{"key":"e_1_2_1_1_10_2","first-page":"339","volume-title":"The pharmacological basis of therapeutics","author":"Harvey SC.","year":"1980"},{"key":"e_1_2_1_1_11_2","volume-title":"Asendin package insert","author":"Lederle Laboratories.","year":"1980"},{"key":"e_1_2_1_1_12_2","first-page":"381","article-title":"Clinical trial of amoxapine (CL\u201067,772) with depressed patients","volume":"14","author":"Ota KY","year":"1972","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_1_13_2","first-page":"449","article-title":"A pilot study of amoxapine (CL\u201067,772) in depressed patients","volume":"14","author":"Kellner R","year":"1972","journal-title":"Cur Ther Res"},{"key":"e_1_2_1_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(80)90213-0"},{"key":"e_1_2_1_1_15_2","first-page":"364","article-title":"CL\u201067,772: A preliminary evaluation of a potential antidepressant compound: Animal and human correlations","volume":"13","author":"Gallant DM","year":"1971","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_1_16_2","first-page":"657","article-title":"Amoxapine: A clinical evaluation in depressive syndromes","volume":"14","author":"Charalampous KD.","year":"1972","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_1_17_2","first-page":"177","article-title":"A double\u2010blind comparison between amoxapine and amitriptyline in depressed in\u2010 patients","volume":"18","author":"Kaumeier HS","year":"1980","journal-title":"Int J Clin Pharm Ther Tox"},{"key":"e_1_2_1_1_18_2","first-page":"633","article-title":"A comparison of the onset of action and therapeutic efficacy of amoxapine and amitriptyline","volume":"39","author":"Hekimian LJ","year":"1978","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_1_19_2","first-page":"11","article-title":"Amoxapine and amitriptyline in the outpatient treatment of endogenous depression","volume":"42","author":"Donlon PT","year":"1981","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_1_20_2","first-page":"304","article-title":"Controlled trial of a new anti\u2010depressive, amoxapine, in comparison with amitriptyline","volume":"22","author":"Aberg A","year":"1977","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_1_21_2","first-page":"165","article-title":"Amoxapine and amitriptyline: A double\u2010blind study in depressed patients","volume":"75","author":"Paula Melo AJM","year":"1977","journal-title":"A Folha Medica"},{"key":"e_1_2_1_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1979.tb00249.x"},{"key":"e_1_2_1_1_23_2","first-page":"502","article-title":"Amoxapine: A double\u2010blind comparative clinical trial of amoxapine and amitriptyline in depressed, hospitalized patients","volume":"21","author":"Yamhure A","year":"1977","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_1_24_2","first-page":"726","article-title":"Amoxapine and amitriptyline: A double\u2010blind study in depressed patients","volume":"25","author":"Sethi BB","year":"1979","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_1_25_2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/030006057900700102","article-title":"Comparison of efficacy of amoxapine and imipramine in a multi\u2010clinic double\u2010blind study using the WHO schedule for a standard assessment of patients with depressive disorders","volume":"7","author":"Takahashi R","year":"1979","journal-title":"J Int Med Res"},{"key":"e_1_2_1_1_26_2","first-page":"197","article-title":"A double\u2010blind comparison of amoxapine and imipramine in depression","volume":"74","author":"Paprocki J","year":"1977","journal-title":"A Folha Medica"},{"key":"e_1_2_1_1_27_2","first-page":"417","article-title":"A double\u2010blind controlled study of amoxapine and imipramine in cases of depression","volume":"26","author":"Bagadia VN","year":"1979","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_1_28_2","first-page":"509","article-title":"Effect of long\u2010term administration of antidepressants (amoxapine and imipramine) on serum anterior pituitary hormone levels in patients with depression and in depressive states","volume":"27","author":"Murasaki M","year":"1979","journal-title":"Horumon To Rinsho"},{"issue":"2","key":"e_1_2_1_1_29_2","article-title":"A double\u2010blind comparative study between amoxapine and imipramine in the treatment of depression","volume":"75","author":"Campos Souza J","year":"1977","journal-title":"A Folha Medica"},{"key":"e_1_2_1_1_30_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007997909109448"},{"key":"e_1_2_1_1_31_2","first-page":"611","article-title":"Double\u2010blind placebo\u2010controlled comparison of amoxapine and imipramine in depressed out\u2010patients","volume":"22","author":"Fabre LF","year":"1977","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_1_32_2","first-page":"68","article-title":"Comparison of the therapeutic efficacy of amoxapine with that of imipramine. A controlled clinical study in patients with depressive illness","volume":"16","author":"Kiev A","year":"1979","journal-title":"Clin Trials J"},{"key":"e_1_2_1_1_33_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.138.1.20"},{"key":"e_1_2_1_1_34_2","first-page":"714","article-title":"A placebo\u2010controlled comparison of amoxapine and imipramine in the treatment of depressed outpatients","volume":"29","author":"Dominguez RA","year":"1981","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_1_35_2","first-page":"346","article-title":"Amoxapine, imipramine, and placebo in depressive illness","volume":"18","author":"Smith RC.","year":"1975","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_1_36_2","first-page":"490","article-title":"Amoxapine, imipramine and placebo: a double\u2010blind study with pretherapy urinary 3\u2010methoxy\u20104\u2010hydroxphenylglycol levels","volume":"26","author":"Steinbook RM","year":"1979","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_1_37_2","first-page":"620","article-title":"A double\u2010blind clinical comparison of amoxapine, imipramine, and placebo in the treatment of depression","volume":"22","author":"Wilson IC","year":"1977","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_1_38_2","first-page":"919","article-title":"Amoxapine and imipramine: a double\u2010blind study in depressed patients","volume":"15","author":"Sathananthan GL","year":"1973","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_1_39_2","first-page":"56","article-title":"Amoxapine: a double\u2010blind evaluation of antidepressant activity","volume":"15","author":"Gallant DM","year":"1973","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_1_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1979.03300170046029"},{"key":"e_1_2_1_1_41_2","first-page":"821","article-title":"Galactorrhea in a patient treated with amoxapine","volume":"39","author":"Jaffe K","year":"1978","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_1_42_2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/archinte.1981.00340080063015","article-title":"The effect of two antidepressants, amoxapine and imipramine, on serum prolactin levels","volume":"141","author":"Cooper DS","year":"1981","journal-title":"Arch Int Med"},{"key":"e_1_2_1_1_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-197910000-00009"},{"key":"e_1_2_1_1_44_2","volume-title":"Quantitative mapping of metabolites of imipramine and desipramine in plasma samples by gas chromatographic\u2010mass spectrometry (abstract)","author":"Narasimhachari N","year":"1980"},{"key":"e_1_2_1_2_2_2","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/0006-2952(79)90017-0","article-title":"2\u2010Chloro\u201011\u2010(1\u2010piperazinyl) dibenz[b,f] [1,4] oxazepine (Amoxapine), an antidepressant with antipsychotic properties \u2014 a possible role for 7\u2010hydroxyamoxapine","volume":"28","author":"Coupet J","year":"1979","journal-title":"Biochem Pharmacol"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1981.tb02538.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1981.tb02538.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1875-9114.1981.tb02538.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:15:54Z","timestamp":1761048954000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/j.1875-9114.1981.tb02538.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,11,12]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1981,11,12]]}},"alternative-id":["10.1002\/j.1875-9114.1981.tb02538.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1875-9114.1981.tb02538.x","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,11,12]]},"assertion":[{"value":"2012-01-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}